Polaris Venture Management Co. V, L.L.C., 10% Owner at T2 Biosystems, Inc. (TTOO), sold 44,997 shares at $16.12 ($731K) on 2015-07-09, disclosed to the SEC on 2015-07-10.
Scheduled sale ($731k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.99 | 99 | $2K | 0.2% |
| 2 | $15.99 | 144 | $2K | 0.3% |
| 3 | $15.99 | 282 | $5K | 0.6% |
| 4 | $15.99 | 14,474 | $231K | 31.7% |
| 5 | $16.12 | 99 | $2K | 0.2% |
| 6 | $16.12 | 144 |
| $2K |
| 0.3% |
| 7 | $16.12 | 282 | $5K | 0.6% |
| 8 | $16.12 | 14,474 | $233K | 31.9% |
| 9 | $16.63 | 99 | $2K | 0.2% |
| 10 | $16.63 | 144 | $2K | 0.3% |
| 11 | $16.63 | 282 | $5K | 0.6% |
| 12 | $16.63 | 14,474 | $241K | 32.9% |
| Total | $16.25 avg | 44,997 | $731K | 100% |
| Filing → |
| CDLX | SELL | 2019-06-06 | $3.6M | — | Filing → |
| CDLX | SELL | 2019-05-30 | $2.3M | — | Filing → |
| CDLX | SELL | 2018-09-14 | $3.8M | — | Filing → |